Global Biological Excipient Market Research Report 2022
1 Biological Excipient Market Overview
- 1.1 Product Overview and Scope of Biological Excipient
- 1.2 Biological Excipient Segment by Type
- 1.2.1 Global Biological Excipient Sales Growth Rate Comparison by Type (2022-2028)
2 Biological Excipient Market Competition by Manufacturers
- 2.1 Global Biological Excipient Sales Market Share by Manufacturers (2017-2022)
- 2.2 Global Biological Excipient Revenue Market Share by Manufacturers (2017-2022)
- 2.3 Global Biological Excipient Average Price by Manufacturers (2017-2022)
- 2.4 Manufacturers Biological Excipient Manufacturing Sites, Area Served, Product Type
- 2.5 Biological Excipient Market Competitive Situation and Trends
- 2.5.1 Biological Excipient Market Concentration Rate
3 Biological Excipient Retrospective Market Scenario by Region
- 3.1 Global Biological Excipient Retrospective Market Scenario in Sales by Region: 2017-2022
- 3.2 Global Biological Excipient Retrospective Market Scenario in Revenue by Region: 2017-2022
- 3.3 North America Biological Excipient Market Facts & Figures by Country
- 3.3.1 North America Biological Excipient Sales by Country
4 Global Biological Excipient Historic Market Analysis by Type
- 4.1 Global Biological Excipient Sales Market Share by Type (2017-2022)
- 4.2 Global Biological Excipient Revenue Market Share by Type (2017-2022)
- 4.3 Global Biological Excipient Price by Type (2017-2022)
5 Global Biological Excipient Historic Market Analysis by Application
- 5.1 Global Biological Excipient Sales Market Share by Application (2017-2022)
- 5.2 Global Biological Excipient Revenue Market Share by Application (2017-2022)
- 5.3 Global Biological Excipient Price by Application (2017-2022)
6 Key Companies Profiled
- 6.1 Ashland Inc.
- 6.1.1 Ashland Inc. Corporation Information
7 Biological Excipient Manufacturing Cost Analysis
- 7.1 Biological Excipient Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Biological Excipient Distributors List
- 8.3 Biological Excipient Customers
9 Biological Excipient Market Dynamics
- 9.1 Biological Excipient Industry Trends
- 9.2 Biological Excipient Market Drivers
- 9.3 Biological Excipient Market Challenges
- 9.4 Biological Excipient Market Restraints
10 Global Market Forecast
- 10.1 Biological Excipient Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Biological Excipient by Type (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
Industry Insights
Due to the COVID-19 pandemic, the global Biological Excipient market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Biological Excipient market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Biological Excipient landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Oral accounting for % of the Biological Excipient global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Biological Excipient include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, Roquette Frères, Signet Chemical Corporation Pvt. Ltd., The Archer Daniels Midland Company and The Dow Chemical Company, etc. In terms of revenue, the global 3 largest players have a % market share of Biological Excipient in 2021.
This report focuses on Biological Excipient volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Biological Excipient market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Biological Excipient market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Oral
Topical
Segment by Application
Hospitals
Clinics
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
Roquette Frères
Signet Chemical Corporation Pvt. Ltd.
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Frequently Asked Questions
Which product segment grabbed the largest share in the Biological Excipient market?
How is the competitive scenario of the Biological Excipient market?
Which are the key factors aiding the Biological Excipient market growth?
Which are the prominent players in the Biological Excipient market?
Which region holds the maximum share in the Biological Excipient market?
What will be the CAGR of the Biological Excipient market during the forecast period?
Which application segment emerged as the leading segment in the Biological Excipient market?
What key trends are likely to emerge in the Biological Excipient market in the coming years?
What will be the Biological Excipient market size by 2028?
Which company held the largest share in the Biological Excipient market?